The Temple Lung Center has one of the most active and wide-ranging pulmonary research programs in the world. Areas of focus include COPD, emphysema, respiratory failure, lung transplantation, pulmonary arterial hypertension, alpha 1-antitrypsin deficiency, asthma, lung cancer, sarcoidosis, pulmonary fibrosis and sleep apnea.
At Temple, research is broadly conducted in two areas – basic-science research and clinical research. Basic-science research largely takes place in modern laboratories at the Lewis Katz School of Medicine at Temple University. Here, Temple scientists seek to better understand the cellular and molecular basis of lung disease and translate those finding into better therapies and methods of prevention.
Temple also maintains a strong clinical research program with studies and clinical trials that test new medications, devices or procedures in patients in order to find more effective treatments. The Temple Lung Center typically has several dozen open clinical trials at any one time and consistently ranks among the highest enrolling sites for pulmonary clinical trials in the nation.
For more information about Temple’s pulmonary focus areas, visit the website for the Center for Inflammation, Translational and Clinical Lung Research.